- Home
- WLDS vs QLGN Comparison
WLDS vs QLGN Comparison
Compare WLDS & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- QLGN
- Stock Information
- Founded
- WLDS 2014
- QLGN 1996
- Country
- WLDS Israel
- QLGN United States
- Employees
- WLDS N/A
- QLGN 4
- Industry
- WLDS Computer Communications Equipment
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- QLGN Health Care
- Exchange
- WLDS Nasdaq
- QLGN Nasdaq
- Market Cap
- WLDS 2.9M
- QLGN 2.7M
- IPO Year
- WLDS 2022
- QLGN N/A
- Fundamental
- Price
- WLDS $1.63
- QLGN $3.60
- Analyst Decision
- WLDS
- QLGN
- Analyst Count
- WLDS 0
- QLGN 0
- Target Price
- WLDS N/A
- QLGN N/A
- AVG Volume (30 Days)
- WLDS 75.2K
- QLGN 226.0K
- Earning Date
- WLDS 11-26-2024
- QLGN 11-29-2024
- Dividend Yield
- WLDS N/A
- QLGN N/A
- EPS Growth
- WLDS N/A
- QLGN N/A
- EPS
- WLDS N/A
- QLGN N/A
- Revenue
- WLDS $464,000.00
- QLGN N/A
- Revenue This Year
- WLDS N/A
- QLGN N/A
- Revenue Next Year
- WLDS N/A
- QLGN N/A
- P/E Ratio
- WLDS N/A
- QLGN N/A
- Revenue Growth
- WLDS 1500.00
- QLGN N/A
- 52 Week Low
- WLDS $1.55
- QLGN $3.55
- 52 Week High
- WLDS $16.00
- QLGN $39.15
- Technical
- Relative Strength Index (RSI)
- WLDS 16.74
- QLGN 25.42
- Support Level
- WLDS $2.33
- QLGN $3.71
- Resistance Level
- WLDS $2.66
- QLGN $4.56
- Average True Range (ATR)
- WLDS 0.33
- QLGN 0.65
- MACD
- WLDS -0.03
- QLGN -0.06
- Stochastic Oscillator
- WLDS 3.90
- QLGN 2.08
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops a non-invasive Neural input interface for controlling digital devices using subtle finger movements. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.